8 results
Opioid Use Disorder Medications - Pharmacokinetics

Buprenorphine is a partial mu-opioid receptor agonist with low intrinsic activity,
Medications - Pharmacokinetics ... margin of safety in pharmacology ... the sublingual tablet ... #Comparison #Table ... #Pharmacology #
Inpatient Management of Opioid Use Disorder: Methadone vs Buprenorphine - Comparison Table

Some patients may decline buprenorphine
Management of Opioid ... Buprenorphine - Comparison Table ... Some patients may ... interested in medication ... Dosing usually begins
The 8 A’s — drugs that interact with warfarin
Antibiotics 
 - Most agents, but especially co-trimoxazole,
with warfarin Antibiotics ... Gingko biloba, dong ... #Interactions #Table ... #Mnemonic #8As ... #Pharmacology #Medications
Rybelsus (oral semaglutide) - First Oral GLP-1 Agonist
Dosing:
3 mg daily x 30 days, then 7 mg
GLP-1 Agonist Dosing ... semaglutide, the same medication ... drug to remain stable ... also because this may ... semaglutide #Diabetes #Pharmacology
IDSA Recommendations for Preventing and Treating Disseminated Mycobacterium Avium Complex in HIV-AIDS
Preventing 1st Episode of Disseminated
IDSA Recommendations ... please refer to Table ... 5 for dosing recommendation ... least 2 drugs as ... infections #HIVAIDS #pharmacology
It is important to recognize Acute Decompensated Heart Failure (ADHF) as more than just simply a
Failure (ADHF) as ... then be excreted using ... algorithm #management #cardiology ... #treatment #table ... icu #clinical #pharmacology
IDSA Recommended Dosages of Antimicrobial Agents Administered by the Intraventricular Route
Amikacin - 5–50 mg
Amphotericin B -
IDSA Recommended ... Intraventricular #antibiotics ... #dosing #pharmacology ... ventriculitis #table ... #idsa
IDSA Recommendations for Treating Mycobacterium Tuberculosis Infection and Disease in HIV-AIDS
Treating LTBI (to prevent TB disease)
Indications:
IDSA Recommendations ... Please refer to the table ... Guidelines for dosing ... Tuberculosis #TB #IDSA ... infections #HIVAIDS #pharmacology